Glympse Bio
Industry
- In Vitro Diagnostics
- Biosensors
- Urine-based Testing
- Therapeutic Drug Monitoring
- Biotechnology
- Drug Discovery Technologies
- Nanotechnology, Chips, etc.
Latest on Glympse Bio
CARGO Therapeutics Inc. executed the 21st initial public offering in the US by a biopharmaceutical company in 2023 and the fifth-largest so far this year when it grossed $281.3m from an offering of 1
“Biomedical innovation is at its golden age, and scientific innovation will continue to be strong,” declared Søren Møller , managing partner at Novo Seeds , the life science start-up financing arm o
Emerging Companies Behind More Approvals Emerging biopharma companies – those that are at clinical or commercial stage with less than $1bn in revenues – are driving more new drug approvals in 2021 tha
Emerging Companies Behind More Approvals Emerging biopharma companies – those that are at clinical or commercial stage with less than $1bn in revenues – are driving more new drug approvals in 2021 tha